Transcranial Direct Current Stimulation and Aphasia Language Therapy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01486654|
Recruitment Status : Completed
First Posted : December 6, 2011
Last Update Posted : May 15, 2017
|Condition or disease||Intervention/treatment||Phase|
|Nonfluent Aphasia Stroke||Device: Transcranial Direct Current Stimulation - Cathodal stimulation Device: Transcranial Direct Current Stimulation - Anodal stimulation Device: Transcranial Direct Current Stimulation - Sham stimulation||Phase 1|
Stroke is the third leading cause of death and the most common cause of disability in the United States. According to the American Stroke Association, the prevalence of stroke in the U.S. is approximately 4.8 million with approximately 700,000 additional strokes occurring annually. Approximately 150,000 to 250,000 stroke survivors becoming severely and permanently disabled each year.
A common neurological deficit among stroke survivors, and thus a substantial contributor to post-stroke disability, is aphasia. The loss of, or difficulty with language is extremely debilitating and has enormous social and economic impact on quality of life. Presently, the only treatment available for persons with aphasia is speech-language rehabilitation.
With rehabilitation only, however, many patients achieve a less than satisfactory improvement in speech-language function, and thus are left with significant disability.
Enhancing stroke recovery by facilitating brain plasticity with the direct application of stimulation to the cerebral cortex is a new area of investigation and shows promise for improving language recovery in stroke-induced aphasia, most probably when it is combined with intense learning. There are several methods of delivering cortical brain stimulation to modulate cortical excitability, each of which have been studied in animal models with promising results, and subsequently applied to the rehabilitation of motor deficits after stroke. Applications to language problems after stroke are only emerging. Nevertheless, results suggest a potential role for cortical stimulation as an adjuvant strategy in aphasia rehabilitation.
Of the cortical stimulation methods available, transcranial direct current stimulation (tDCS) has the greatest potential for clinical use in view of its non-invasive application, ease of administration and relatively low cost. tDCS is a method of delivering weak polarizing electrical currents to the cortex via two electrodes placed on the scalp. The nature of the effect depends on the polarity of the current. Anodal tDCS has an excitatory effect; cathodal tDCS induces inhibition.
This study proposes to evaluate the safety, feasibility, and effectiveness of anodal and cathodal tDCS in study subjects with Broca's aphasia after stroke, delivered concurrent with speech-language rehabilitation.
Subjects will receive speech and language therapy combined with either anodal, cathodal, or sham stimulation applied to the lesioned left hemisphere. The polarity conditions will be compared with each other and with sham stimulation, to determine safety, the degree to which improvements in language performance occur, and the degree to which they are maintained over time.
The protocol is single-blind. Neither the subjects nor the outcomes assessor will know what stimulation the subject received until the study's conclusion; the investigator applying the stimulation will know.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||12 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Transcranial Direct Current Stimulation and Aphasia Language Therapy|
|Study Start Date :||March 2010|
|Actual Primary Completion Date :||December 2016|
|Actual Study Completion Date :||December 2016|
|Active Comparator: Anodal stimulation||
Device: Transcranial Direct Current Stimulation - Anodal stimulation
Anodal transcranial direct stimulation (tDCS) to the left hemisphere, 1.0 mA for 13 minutes, is received five days a week, for six weeks, during the initial 13 minutes of 90 minutes of speech-language treatment.
|Active Comparator: Cathodal stimulation||
Device: Transcranial Direct Current Stimulation - Cathodal stimulation
Cathodal transcranial direct stimulation (tDCS) to the left hemisphere, 1.0 mA for 13 minutes, is received five days a week, for six weeks, during the initial 13 minutes of 90 minutes of speech-language treatment.
|Placebo Comparator: Sham stimulation||
Device: Transcranial Direct Current Stimulation - Sham stimulation
Sham stimulation provided together with 90 minutes of speech language therapy, 5 days a week, for 6 weeks.
Other Name: No stimulation
- Aphasia Quotient (AQ) on the Western Aphasia Battery [ Time Frame: Change from Baseline in Western Aphasia Battery at 6 weeks ]
- Functional communication skills [ Time Frame: Change from Baseline in functional communication skills at 6 weeks ]Scores derived from language sample analyses
- Participation in everyday activities [ Time Frame: Change from Baseline in participation in everyday activities at 6 weeks ]Measures on CETI, BOSS, CCRSA
- Western Aphasia Battery - Reading and Writing scores [ Time Frame: Change from Baseline in Western Aphasia Battery Reading and Writing scores at 6 weeks ]
- Western Aphasia Battery Aphasia Quotient (Maintenance) [ Time Frame: Change in Western Aphasia Battery AQ from 6 weeks to 12 weeks ]
- Western Aphasia Battery Reading and Writing Scores (Maintenance) [ Time Frame: Change in WAB Reading and Writing Skills from 6 weeks to 12 weeks ]
- Functional Communication Skills (Maintenance) [ Time Frame: Communication skills from 6 weeks to 12 weeks ]
- Participation in everyday activities (Maintenance) [ Time Frame: Change in participation in everyday activities from 6 weeks to 12 weeks ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01486654
|United States, Illinois|
|Center for Aphasia Research & Treatment, Rehabilitation Institute of Chicago|
|Chicago, Illinois, United States, 60611|
|Principal Investigator:||Leora R Cherney, PhD||Rehabilitation Institute of Chicago, Chicago, IL|